r/r dlbcl challanges: novel therapeutics
Published 5 years ago • 83 plays • Length 1:15Download video MP4
Download video MP3
Similar videos
-
3:39
the role of novel therapies in r/r dlbcl
-
1:09
the changing role of allosct in dlbcl in the era of novel agents
-
1:28
novel ultra-sensitive mrd profiling tool predicts outcomes in dlbcl after frontline treatment
-
1:28
how the standard of care for dlbcl is changing with the introduction of novel agents
-
1:19
real-world outcomes of liso-cel therapy in r/r dlbcl
-
1:52
the sequencing of therapies for r/r mcl: btkis and novel agents
-
3:08
welcome to the video journal of hematology & hematological oncology 🎥🩸
-
31:40
unlocking data insights on benchling for novel rna therapeutic delivery methods
-
5:10
getting started with r: mean, median, and standard deviation
-
9:25
mgus diagnosis: a step-by-step approach
-
1:12
exciting advances in dlbcl: molecular characterization of subtypes & novel immunotherapeutic agents
-
1:18
updates in the treatment of r/r lbcl: promising novel agents in the pipeline
-
1:16
how novel immunotherapies have impacted the treatment of r/r all
-
3:58
phase ib/iia study of azd4573 acalabrutinib in r/r dlbcl
-
0:55
the role of rna modifications in mds and aml
-
1:33
the difficulties of mrd detection in dlbcl
-
1:57
using ai to predict the outcomes of patients with r/r dlbcl treated with tisagenlecleucel
-
2:38
car-t therapy for aggressive b-cell lymphomas
-
1:54
the important role of bispecific antibodies in the future treatment of r/r dlbcl
-
2:49
insights into the role of novel btkis in the treatment landscape of r/r cll
-
0:42
targeted therapies for dlbcl treatment